BGM Group Ltd Ordinary Shares - Class A BGM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.29
- Day Range
- $0.28–0.31
- 52-Week Range
- $0.26–11.80
- Bid/Ask
- $0.29 / $0.31
- Shares Outstanding
- 400.62M
- Market Cap
- $112.86M
- Volume/Avg
- 50,462 / 442,405
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 323
- Website
- https://www.bgmgroupltd.com
Valuation
|
Metric
|
BGM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.15 |
Price/Sales | 0.20 |
Price/Cash Flow | — |
Price/Earnings
BGM
Financial Strength
|
Metric
|
BGM
|
|---|---|
Quick Ratio | 1.33 |
Current Ratio | 1.82 |
Interest Coverage | −10.20 |
Quick Ratio
BGM
Profitability
|
Metric
|
BGM
|
|---|---|
Return on Assets (Normalized) | 2.46% |
Return on Equity (Normalized) | 2.85% |
Return on Invested Capital (Normalized) | 3.53% |
Return on Assets
BGM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|r<@h!!%! | LOCK|Pkb# | $68B | |||
| Haleon PLC ADR
HLN
| LOCK|#n?$M&@ | LOCK|%kK | $44B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|?@h<<D%< | LOCK|P?m>> | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|r?!mVfX | LOCK|Sq< | $32B | |||
| Viatris Inc
VTRS
| LOCK|pqwxZ^M | LOCK|Y$J | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|t@ | LOCK|$h | $13B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|$C%z!X | LOCK|#&^ | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|>>dKb%? | LOCK|sR@ | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|&LX%f< | LOCK|&h<VQ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|#V$<N> | LOCK|l^ | $1B |
United States